A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
Clinical trial NCT05061420 · TERMINATED
Trial details
- NCT number
- NCT05061420
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-08
- Primary completion
- 2023-07-21
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.